People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| AcuFocus, Inc. | — | Biotechnology | Series C | $167.7M | $981.9M | 2016 |
| CardioFocus, Inc. | — | Biotechnology | Series B | $153.2M | $351.9M | 2009 |
| Self Financial, Inc. | — | Other Technology | Series C | $126.1M | $1.2B | 2015 |
| Ocular Therapeutix, Inc | — | Biotechnology | Series B | $81.0M | $1.5B | 2009 |
| Halscion Inc | — | Biotechnology | Series A | $13.8M | $155.4M | 2011 |
| Cellutions Inc | — | Biotechnology | Pre-Seed | $1.0M | $55.2M | 2009 |
James Garvey at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James Garvey on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Charles Larsen | 3 | 7 |
| Anthony Lando | 2 | 6 |
| Charles Warden | 2 | 5 |
| Kathleen Beauchamp | 2 | 2 |
| Morgan Flager | 1 | 20 |
| Christopher Brown | 1 | 16 |
| FARHAD KHOSRAVI | 1 | 14 |
| Richard Lindstrom | 1 | 13 |
| PAUL LAVIOLETTE | 1 | 12 |
| William J. Link | 1 | 10 |
| Alan Crane | 1 | 9 |
| Brian Levy | 1 | 8 |
| Buzz Benson | 1 | 8 |
| Anthony Lee | 1 | 8 |
| Amarpreet Sawhney | 1 | 8 |
| Richard L Lindstrom | 1 | 8 |
| Ryan Schwarz | 1 | 7 |
| Bruce Robertson | 1 | 7 |
| Gerard Van Hamel Platerink | 1 | 6 |
| Robert E. Grant | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.